Cargando…
Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection
Since the appearance of the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 in China, diabetes mellitus (DM) and hyperglycemia in patients infected with SARS-CoV, represent independent predictors of mortality. Therefore, metabolic control has played a major role in the prognosis of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792738/ https://www.ncbi.nlm.nih.gov/pubmed/35096863 http://dx.doi.org/10.3389/fmed.2021.758414 |
_version_ | 1784640443434139648 |
---|---|
author | Vargas-Rodriguez, Jose R. Garza-Veloz, Idalia Flores-Morales, Virginia Badillo-Almaraz, Jose I. Rocha-Pizaña, Maria R. Valdés-Aguayo, José J. Martinez-Fierro, Margarita L. |
author_facet | Vargas-Rodriguez, Jose R. Garza-Veloz, Idalia Flores-Morales, Virginia Badillo-Almaraz, Jose I. Rocha-Pizaña, Maria R. Valdés-Aguayo, José J. Martinez-Fierro, Margarita L. |
author_sort | Vargas-Rodriguez, Jose R. |
collection | PubMed |
description | Since the appearance of the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 in China, diabetes mellitus (DM) and hyperglycemia in patients infected with SARS-CoV, represent independent predictors of mortality. Therefore, metabolic control has played a major role in the prognosis of these patients. In the current pandemic of coronavirus disease 19 (COVID-19), multiple studies have shown that DM is one of the main comorbidities associated with COVID-19 and higher risk of complications and death. The incidence and prevalence of COVID-19 complications and death related with hyperglycemia in patients with or without DM are high. There are many hypotheses related with worse prognosis and death related to COVID-19 and/or hyperglycemia. However, the information about the interplay between hyperglycemia and angiotensin-converting enzyme 2 (ACE2), the critical receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the context of SARS-CoV-2 infection, is almost null, but there is enough information to consider the possible participation of hyperglycemia in the glycation of this protein, unleashing a pool of reactions leading to acute respiratory distress syndrome and death in patients with COVID-19. In this document we investigated the current evidence related with ACE2 as a key element within the pathophysiological mechanism related with hyperglycemia extrapolating it to context of SARS-CoV-2 infection and its relationship with worse prognosis and death for COVID-19. |
format | Online Article Text |
id | pubmed-8792738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87927382022-01-28 Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection Vargas-Rodriguez, Jose R. Garza-Veloz, Idalia Flores-Morales, Virginia Badillo-Almaraz, Jose I. Rocha-Pizaña, Maria R. Valdés-Aguayo, José J. Martinez-Fierro, Margarita L. Front Med (Lausanne) Medicine Since the appearance of the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 in China, diabetes mellitus (DM) and hyperglycemia in patients infected with SARS-CoV, represent independent predictors of mortality. Therefore, metabolic control has played a major role in the prognosis of these patients. In the current pandemic of coronavirus disease 19 (COVID-19), multiple studies have shown that DM is one of the main comorbidities associated with COVID-19 and higher risk of complications and death. The incidence and prevalence of COVID-19 complications and death related with hyperglycemia in patients with or without DM are high. There are many hypotheses related with worse prognosis and death related to COVID-19 and/or hyperglycemia. However, the information about the interplay between hyperglycemia and angiotensin-converting enzyme 2 (ACE2), the critical receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the context of SARS-CoV-2 infection, is almost null, but there is enough information to consider the possible participation of hyperglycemia in the glycation of this protein, unleashing a pool of reactions leading to acute respiratory distress syndrome and death in patients with COVID-19. In this document we investigated the current evidence related with ACE2 as a key element within the pathophysiological mechanism related with hyperglycemia extrapolating it to context of SARS-CoV-2 infection and its relationship with worse prognosis and death for COVID-19. Frontiers Media S.A. 2022-01-13 /pmc/articles/PMC8792738/ /pubmed/35096863 http://dx.doi.org/10.3389/fmed.2021.758414 Text en Copyright © 2022 Vargas-Rodriguez, Garza-Veloz, Flores-Morales, Badillo-Almaraz, Rocha-Pizaña, Valdés-Aguayo and Martinez-Fierro. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Vargas-Rodriguez, Jose R. Garza-Veloz, Idalia Flores-Morales, Virginia Badillo-Almaraz, Jose I. Rocha-Pizaña, Maria R. Valdés-Aguayo, José J. Martinez-Fierro, Margarita L. Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection |
title | Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection |
title_full | Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection |
title_fullStr | Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection |
title_full_unstemmed | Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection |
title_short | Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection |
title_sort | hyperglycemia and angiotensin-converting enzyme 2 in pulmonary function in the context of sars-cov-2 infection |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792738/ https://www.ncbi.nlm.nih.gov/pubmed/35096863 http://dx.doi.org/10.3389/fmed.2021.758414 |
work_keys_str_mv | AT vargasrodriguezjoser hyperglycemiaandangiotensinconvertingenzyme2inpulmonaryfunctioninthecontextofsarscov2infection AT garzavelozidalia hyperglycemiaandangiotensinconvertingenzyme2inpulmonaryfunctioninthecontextofsarscov2infection AT floresmoralesvirginia hyperglycemiaandangiotensinconvertingenzyme2inpulmonaryfunctioninthecontextofsarscov2infection AT badilloalmarazjosei hyperglycemiaandangiotensinconvertingenzyme2inpulmonaryfunctioninthecontextofsarscov2infection AT rochapizanamariar hyperglycemiaandangiotensinconvertingenzyme2inpulmonaryfunctioninthecontextofsarscov2infection AT valdesaguayojosej hyperglycemiaandangiotensinconvertingenzyme2inpulmonaryfunctioninthecontextofsarscov2infection AT martinezfierromargarital hyperglycemiaandangiotensinconvertingenzyme2inpulmonaryfunctioninthecontextofsarscov2infection |